GS0421: Research and development of therapeutics for the treatment of neuromuscular, neurologic and other diseases; Research and development of peptide-conjugated therapeutics for the treatment of neuromuscular, neurologic and other diseases; Research and development of a drug delivery platform and conjugate therapeutics for the treatment of neuromuscular, neurologic and other diseases
Case File Event Statements
4/11/2023 - a year ago
15 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
4/11/2023 - a year ago
14 - REGISTERED-PRINCIPAL REGISTERType:R.PR
1/24/2023 - 2 years ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
1/24/2023 - 2 years ago
12 - PUBLISHED FOR OPPOSITIONType:PUBO
1/4/2023 - 2 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
12/19/2022 - 2 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/16/2022 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/15/2022 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/15/2022 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
12/2/2022 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
12/2/2022 - 2 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
12/2/2022 - 2 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
12/1/2022 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
10/24/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS